176 related articles for article (PubMed ID: 21318603)
1. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
[TBL] [Abstract][Full Text] [Related]
2. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
[TBL] [Abstract][Full Text] [Related]
4. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.
Francisco G; Menezes PR; Eluf-Neto J; Chammas R
Eur J Hum Genet; 2008 Jun; 16(6):724-34. PubMed ID: 18285822
[TBL] [Abstract][Full Text] [Related]
5. Associations between XPC polymorphisms and risk of cancers: A meta-analysis.
Qiu L; Wang Z; Shi X; Wang Z
Eur J Cancer; 2008 Oct; 44(15):2241-53. PubMed ID: 18771913
[TBL] [Abstract][Full Text] [Related]
6. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
7. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
[TBL] [Abstract][Full Text] [Related]
8. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis.
Huang Q; Wang C; Qiu LJ; Shao F; Yu JH
Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
Ding DP; He XF; Zhang Y
Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776
[TBL] [Abstract][Full Text] [Related]
10. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
[TBL] [Abstract][Full Text] [Related]
11. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
[TBL] [Abstract][Full Text] [Related]
12. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.
Qiu LX; Yao L; Yuan H; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546
[TBL] [Abstract][Full Text] [Related]
13. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
[TBL] [Abstract][Full Text] [Related]
14. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ
Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.
Qiu LX; Yuan H; Yu KD; Mao C; Chen B; Zhan P; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Jun; 121(3):703-8. PubMed ID: 19936916
[TBL] [Abstract][Full Text] [Related]
16. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Xue K; Zhang J; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
[TBL] [Abstract][Full Text] [Related]
17. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
19. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():120. PubMed ID: 24947936
[TBL] [Abstract][Full Text] [Related]
20. Lack of associations between XPC polymorphisms and colorectal cancer: a meta-analysis.
Wang G; Sun H; Liu Z; Huang R; Chen Y; Tang Q; Yu L; Jiang Z; Wang X
J BUON; 2015; 20(3):770-4. PubMed ID: 26214629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
